Konski Quoted on Patent Office's Post-Myriad Guide

Partner Antoinette Konski was quoted in an FDA Week article on March 13, 2014 titled, “Gene Patent Experts Disagree About Patent Office’s Post-Myriad Guide.” The article discusses how experts are split on new guidance from the U.S. Patent and Trademark Office outlining when products that use naturally occurring genetic materials are patentable following a Supreme Court decision invalidating patents on naturally occurring DNA. Konski was quoted saying, “The guidance does not provide clear examples of marked differences that relate to current technology.”